Nephrology Times
Advertisement
A bill to improve access to care and outcomes for some dialysis patients was introduced in the House of Representatives.
Research has begun to question recommendations to restrict potassium with CKD to manage hyperkalemia.
Will sparsentan prove a winner for patients with FSGS, or are we doomed to forever treat them with Acthar Gel?
There are few data on whether the survival benefit of kidney transplantation is different for men and women.
American Society of Nephrology leaders met with Congress to urge increased funding to support organ transplantation.
Opinions differ on the use of no anticoagulation versus regional citrate anticoagulation for treatment of AKI with CKRT.
We've all been guilted into ordering inpatient blood pressure meds. Tim Anderson, MD, asks, "Why?"
Interim analysis from the APPLAUSE-IgAN trial found favorable results for the use of iptacopan in IgAN.
A super-learner strategy gave accurate risk predictions of kidney failure and death for people with moderate to severe CKD.
Longer follow-up results of the RUBY-3 trial found povetacicept is well-tolerated and shows promise for IgAN treatment.
Researchers uncovered clinical and economic of the Kidney BEAM physical activity digital health intervention for CKD.
What can the Gila monster and mourning dove teach us about comparative nephrology?
A study examined the risk factors, prevalence, and impact of pruritus associated with CKD in hemodialysis patients.
Researchers found that sparsentan had a clinically meaningful benefit on long-term kidney preservation versus irbesartan.
Outset Medical has joined the American Nephrology Nurses Association's Partnership Advisory Council.
Researchers studied the prevalence of hyperkalemia in patients at a facility in Durban, South Africa.
Review Dr. Burton Rose's writings on treatment options for hypovolemic states and hypovolemic shock.
Use of antidepressants among patients with CKD is widespread but few data are available on their safety in this population.
Researchers reported on real-world use of SZC for hyperkalemia in a cohort of Asian hemodialysis patients.
The AAKP awarded Dr. Barry Smith the 2024 Medal of Excellence Award in the physician category.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.